WordNet
- a cellular structure that is postulated to exist in order to mediate between a chemical agent that acts on nervous tissue and the physiological response
- the 24th letter of the Roman alphabet (同)x, ex
PrepTutorEJDIC
- =sense organ / 受信装置
- Christ / Christian
- x-axis
Wikipedia preview
出典(authority):フリー百科事典『ウィキペディア(Wikipedia)』「2016/03/29 21:49:05」(JST)
[Wiki en表示]
Nuclear receptor subfamily 1, group H, member 4 |
PDB rendering based on 1osh.
|
Available structures |
PDB |
Ortholog search: PDBe, RCSB |
List of PDB id codes |
1OSH, 1OSK, 3BEJ, 3DCT, 3DCU, 3FLI, 3FXV, 3GD2, 3HC5, 3HC6, 3L1B, 3OKH, 3OKI, 3OLF, 3OMK, 3OMM, 3OOF, 3OOK, 3P88, 3P89, 3RUT, 3RUU, 3RVF, 4OIV, 4WVD
|
|
|
Identifiers |
Symbols |
NR1H4 ; BAR; FXR; HRR-1; HRR1; RIP14 |
External IDs |
OMIM: 603826 MGI: 1352464 HomoloGene: 3760 IUPHAR: 603 ChEMBL: 2047 GeneCards: NR1H4 Gene |
Gene ontology |
Molecular function |
• RNA polymerase II distal enhancer sequence-specific DNA binding
• transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding
• transcriptional activator activity, RNA polymerase II transcription factor binding
• transcription factor activity, sequence-specific DNA binding
• transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding
• steroid hormone receptor activity
• transcription coactivator activity
• transcription corepressor activity
• RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding
• thyroid hormone receptor activity
• protein binding
• zinc ion binding
• ligand-dependent nuclear receptor binding
• bile acid binding
• bile acid receptor activity
• sequence-specific DNA binding
• retinoid X receptor binding
• chenodeoxycholic acid binding
|
Cellular component |
• nucleoplasm
• nuclear euchromatin
|
Biological process |
• negative regulation of transcription from RNA polymerase II promoter
• nitrogen catabolite activation of transcription from RNA polymerase II promoter
• transcription initiation from RNA polymerase II promoter
• signal transduction
• bile acid metabolic process
• gene expression
• bile acid and bile salt transport
• intracellular receptor signaling pathway
• regulation of urea metabolic process
• intracellular bile acid receptor signaling pathway
• steroid hormone mediated signaling pathway
• small molecule metabolic process
• positive regulation of transcription from RNA polymerase II promoter
• regulation of bile acid biosynthetic process
• negative regulation of bile acid biosynthetic process
• cellular response to organonitrogen compound
• regulation of cholesterol metabolic process
• cellular response to bile acid
• positive regulation of glutamate metabolic process
• positive regulation of ammonia assimilation cycle
|
Sources: Amigo / QuickGO |
|
RNA expression pattern |
|
More reference expression data |
Orthologs |
Species |
Human |
Mouse |
Entrez |
9971 |
20186 |
Ensembl |
ENSG00000012504 |
ENSMUSG00000047638 |
UniProt |
Q96RI1 |
Q60641 |
RefSeq (mRNA) |
NM_001206977 |
NM_001163504 |
RefSeq (protein) |
NP_001193906 |
NP_001156976 |
Location (UCSC) |
Chr 12:
100.47 – 100.56 Mb |
Chr 10:
89.45 – 89.53 Mb |
PubMed search |
[1] |
[2] |
|
The bile acid receptor (BAR), also known as farnesoid X receptor (FXR) or NR1H4 (nuclear receptor subfamily 1, group H, member 4) is a nuclear receptor that is encoded by the NR1H4 gene in humans.[1][2]
Contents
- 1 Function
- 2 Interactions
- 3 Ligands
- 4 References
- 5 Further reading
- 6 External links
Function
FXR is expressed at high levels in the liver and intestine. Chenodeoxycholic acid and other bile acids are natural ligands for FXR. Similar to other nuclear receptors, when activated, FXR translocates to the cell nucleus, forms a dimer (in this case a heterodimer with RXR) and binds to hormone response elements on DNA, which up- or down-regulates the expression of certain genes.[2]
One of the primary functions of FXR activation is the suppression of cholesterol 7 alpha-hydroxylase (CYP7A1), the rate-limiting enzyme in bile acid synthesis from cholesterol. FXR does not directly bind to the CYP7A1 promoter. Rather, FXR induces expression of small heterodimer partner (SHP), which then functions to inhibit transcription of the CYP7A1 gene. In this way a negative feedback pathway is established in which synthesis of bile acids is inhibited when cellular levels are already high. FXR has also been found to be important in regulation of hepatic triglyceride levels.[3] Studies have also shown the FXR to regulate the expression and activity of epithelial transport proteins involved in fluid homestasis in the intestine, such as the cystic fibrosis conductance transmembrane regulator (CFTR).[4]
Interactions
Farnesoid X receptor has been shown to interact with:
- Peroxisome proliferator-activated receptor gamma coactivator 1-alpha[5] and
- Retinoid X receptor alpha.[6]
Ligands
A number of ligands for FXR are known, of both natural and synthetic origin.[7][8][9]
- Agonists
- Cafestol[10]
- Chenodeoxycholic acid
- Obeticholic acid
- Fexaramine
- Antagonists
References
- ^ "Entrez Gene: NR1H4 nuclear receptor subfamily 1, group H, member 4".
- ^ a b Forman BM, Goode E, Chen J, Oro AE, Bradley DJ, Perlmann T, Noonan DJ, Burka LT, McMorris T, Lamph WW, Evans RM, Weinberger C (Jun 1995). "Identification of a nuclear receptor that is activated by farnesol metabolites". Cell 81 (5): 687–93. doi:10.1016/0092-8674(95)90530-8. PMID 7774010.
- ^ Jiao Y, Lu Y, Li XY (Jan 2015). "Farnesoid X receptor: a master regulator of hepatic triglyceride and glucose homeostasis". Acta Pharmacologica Sinica 36 (1): 44–50. doi:10.1038/aps.2014.116. PMID 25500875.
- ^ Mroz MS, Keating N, Ward JB, Sarker R, Amu S, Aviello G, Donowitz M, Fallon PG, Keely SJ (May 2014). "Farnesoid X receptor agonists attenuate colonic epithelial secretory function and prevent experimental diarrhoea in vivo". Gut 63 (5): 808–17. doi:10.1136/gutjnl-2013-305088. PMID 23916961.
- ^ Zhang Y, Castellani LW, Sinal CJ, Gonzalez FJ, Edwards PA (Jan 2004). "Peroxisome proliferator-activated receptor-gamma coactivator 1alpha (PGC-1alpha) regulates triglyceride metabolism by activation of the nuclear receptor FXR". Genes & Development 18 (2): 157–69. doi:10.1101/gad.1138104. PMC 324422. PMID 14729567.
- ^ Seol W, Choi HS, Moore DD (Jan 1995). "Isolation of proteins that interact specifically with the retinoid X receptor: two novel orphan receptors". Molecular Endocrinology 9 (1): 72–85. doi:10.1210/mend.9.1.7760852. PMID 7760852.
- ^ Fiorucci S, Zampella A, Distrutti E (2012). "Development of FXR, PXR and CAR agonists and antagonists for treatment of liver disorders". Current Topics in Medicinal Chemistry 12 (6): 605–24. doi:10.2174/156802612799436678. PMID 22242859.
- ^ Fiorucci S, Mencarelli A, Distrutti E, Zampella A (May 2012). "Farnesoid X receptor: from medicinal chemistry to clinical applications". Future Medicinal Chemistry 4 (7): 877–91. doi:10.4155/fmc.12.41. PMID 22571613.
- ^ Vaz B, de Lera ÁR (Nov 2012). "Advances in drug design with RXR modulators". Expert Opinion on Drug Discovery 7 (11): 1003–16. doi:10.1517/17460441.2012.722992. PMID 22954251.
- ^ Ricketts ML, Boekschoten MV, Kreeft AJ, Hooiveld GJ, Moen CJ, Müller M, Frants RR, Kasanmoentalib S, Post SM, Princen HM, Porter JG, Katan MB, Hofker MH, Moore DD (Jul 2007). "The cholesterol-raising factor from coffee beans, cafestol, as an agonist ligand for the farnesoid and pregnane X receptors". Molecular Endocrinology 21 (7): 1603–16. doi:10.1210/me.2007-0133. PMID 17456796.
Further reading
- Kalaany NY, Mangelsdorf DJ (2006). "LXRS and FXR: the yin and yang of cholesterol and fat metabolism". Annual Review of Physiology 68: 159–91. doi:10.1146/annurev.physiol.68.033104.152158. PMID 16460270.
- Kuipers F, Stroeve JH, Caron S, Staels B (Jun 2007). "Bile acids, farnesoid X receptor, atherosclerosis and metabolic control". Current Opinion in Lipidology 18 (3): 289–97. doi:10.1097/MOL.0b013e3281338d08. PMID 17495603.
- Seol W, Choi HS, Moore DD (Jan 1995). "Isolation of proteins that interact specifically with the retinoid X receptor: two novel orphan receptors". Molecular Endocrinology 9 (1): 72–85. doi:10.1210/mend.9.1.7760852. PMID 7760852.
- Zavacki AM, Lehmann JM, Seol W, Willson TM, Kliewer SA, Moore DD (Jul 1997). "Activation of the orphan receptor RIP14 by retinoids". Proceedings of the National Academy of Sciences of the United States of America 94 (15): 7909–14. doi:10.1073/pnas.94.15.7909. PMC 21528. PMID 9223286.
- Makishima M, Okamoto AY, Repa JJ, Tu H, Learned RM, Luk A, Hull MV, Lustig KD, Mangelsdorf DJ, Shan B (May 1999). "Identification of a nuclear receptor for bile acids". Science 284 (5418): 1362–5. doi:10.1126/science.284.5418.1362. PMID 10334992.
- Parks DJ, Blanchard SG, Bledsoe RK, Chandra G, Consler TG, Kliewer SA, Stimmel JB, Willson TM, Zavacki AM, Moore DD, Lehmann JM (May 1999). "Bile acids: natural ligands for an orphan nuclear receptor". Science 284 (5418): 1365–8. doi:10.1126/science.284.5418.1365. PMID 10334993.
- Bramlett KS, Yao S, Burris TP (Dec 2000). "Correlation of farnesoid X receptor coactivator recruitment and cholesterol 7alpha-hydroxylase gene repression by bile acids". Molecular Genetics and Metabolism 71 (4): 609–15. doi:10.1006/mgme.2000.3106. PMID 11136553.
- Stegh AH, Barnhart BC, Volkland J, Algeciras-Schimnich A, Ke N, Reed JC, Peter ME (Feb 2002). "Inactivation of caspase-8 on mitochondria of Bcl-xL-expressing MCF7-Fas cells: role for the bifunctional apoptosis regulator protein". The Journal of Biological Chemistry 277 (6): 4351–60. doi:10.1074/jbc.M108947200. PMID 11733517.
- Cui J, Heard TS, Yu J, Lo JL, Huang L, Li Y, Schaeffer JM, Wright SD (Jul 2002). "The amino acid residues asparagine 354 and isoleucine 372 of human farnesoid X receptor confer the receptor with high sensitivity to chenodeoxycholate". The Journal of Biological Chemistry 277 (29): 25963–9. doi:10.1074/jbc.M200824200. PMID 12004058.
- Huber RM, Murphy K, Miao B, Link JR, Cunningham MR, Rupar MJ, Gunyuzlu PL, Haws TF, Kassam A, Powell F, Hollis GF, Young PR, Mukherjee R, Burn TC (May 2002). "Generation of multiple farnesoid-X-receptor isoforms through the use of alternative promoters". Gene 290 (1-2): 35–43. doi:10.1016/S0378-1119(02)00557-7. PMID 12062799.
- Pineda Torra I, Claudel T, Duval C, Kosykh V, Fruchart JC, Staels B (Feb 2003). "Bile acids induce the expression of the human peroxisome proliferator-activated receptor alpha gene via activation of the farnesoid X receptor". Molecular Endocrinology 17 (2): 259–72. doi:10.1210/me.2002-0120. PMID 12554753.
- Anisfeld AM, Kast-Woelbern HR, Meyer ME, Jones SA, Zhang Y, Williams KJ, Willson T, Edwards PA (May 2003). "Syndecan-1 expression is regulated in an isoform-specific manner by the farnesoid-X receptor". The Journal of Biological Chemistry 278 (22): 20420–8. doi:10.1074/jbc.M302505200. PMID 12660231.
- Pircher PC, Kitto JL, Petrowski ML, Tangirala RK, Bischoff ED, Schulman IG, Westin SK (Jul 2003). "Farnesoid X receptor regulates bile acid-amino acid conjugation". The Journal of Biological Chemistry 278 (30): 27703–11. doi:10.1074/jbc.M302128200. PMID 12754200.
- Zhao A, Lew JL, Huang L, Yu J, Zhang T, Hrywna Y, Thompson JR, de Pedro N, Blevins RA, Peláez F, Wright SD, Cui J (Aug 2003). "Human kininogen gene is transactivated by the farnesoid X receptor". The Journal of Biological Chemistry 278 (31): 28765–70. doi:10.1074/jbc.M304568200. PMID 12761213.
- Barbier O, Torra IP, Sirvent A, Claudel T, Blanquart C, Duran-Sandoval D, Kuipers F, Kosykh V, Fruchart JC, Staels B (Jun 2003). "FXR induces the UGT2B4 enzyme in hepatocytes: a potential mechanism of negative feedback control of FXR activity". Gastroenterology 124 (7): 1926–40. doi:10.1016/S0016-5085(03)00388-3. PMID 12806625.
- Holt JA, Luo G, Billin AN, Bisi J, McNeill YY, Kozarsky KF, Donahee M, Wang DY, Mansfield TA, Kliewer SA, Goodwin B, Jones SA (Jul 2003). "Definition of a novel growth factor-dependent signal cascade for the suppression of bile acid biosynthesis". Genes & Development 17 (13): 1581–91. doi:10.1101/gad.1083503. PMC 196131. PMID 12815072.
- Claudel T, Inoue Y, Barbier O, Duran-Sandoval D, Kosykh V, Fruchart J, Fruchart JC, Gonzalez FJ, Staels B (Aug 2003). "Farnesoid X receptor agonists suppress hepatic apolipoprotein CIII expression". Gastroenterology 125 (2): 544–55. doi:10.1016/S0016-5085(03)00896-5. PMID 12891557.
- Hsiao PW, Fryer CJ, Trotter KW, Wang W, Archer TK (Sep 2003). "BAF60a mediates critical interactions between nuclear receptors and the BRG1 chromatin-remodeling complex for transactivation". Molecular and Cellular Biology 23 (17): 6210–20. doi:10.1128/MCB.23.17.6210-6220.2003. PMC 180928. PMID 12917342.
- Ryan KK, Tremaroli V, Clemmensen C, Kovatcheva-Datchary P, Myronovych A, Karns R, Wilson-Pérez HE, Sandoval DA, Kohli R, Bäckhed F, Seeley RJ (May 2014). "FXR is a molecular target for the effects of vertical sleeve gastrectomy". Nature 509 (7499): 183–8. doi:10.1038/nature13135. PMC 4016120. PMID 24670636.
External links
- "Farnesoid X Receptor (NR1H4)". Nuclear Receptor Resource.
- farnesoid X-activated receptor at the US National Library of Medicine Medical Subject Headings (MeSH)
PDB gallery
|
|
|
1osh: A Chemical, Genetic, and Structural Analysis of the nuclear bile acid receptor FXR
|
|
1osv: STRUCTURAL BASIS FOR BILE ACID BINDING AND ACTIVATION OF THE NUCLEAR RECEPTOR FXR
|
|
1ot7: Structural Basis for 3-deoxy-CDCA Binding and Activation of FXR
|
|
|
|
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
English Journal
- Bile Acids Increase Independently From Hypocaloric Restriction After Bariatric Surgery.
- Jahansouz C1, Xu H, Hertzel AV, Serrot FJ, Kvalheim N, Cole A, Abraham A, Luthra G, Ewing K, Leslie DB, Bernlohr DA, Ikramuddin S.
- Annals of surgery.Ann Surg.2016 Dec;264(6):1022-1028.
- OBJECTIVES: To measure changes in the composition of serum bile acids (BA) and the expression of Takeda G-protein-coupled receptor 5 (TGR5) acutely after bariatric surgery or caloric restriction.SUMMARY BACKGROUND DATA: Metabolic improvement after bariatric surgery occurs before substantial weight l
- PMID 26655924
- Conformational modulation of the farnesoid X receptor by prenylflavonoids: Insights from hydrogen deuterium exchange mass spectrometry (HDX-MS), fluorescence titration and molecular docking studies.
- Yang L1, Broderick D1, Campbell Y2, Gombart AF2, Stevens JF3, Jiang Y4, Hsu VL5, Bisson WH6, Maier CS7.
- Biochimica et biophysica acta.Biochim Biophys Acta.2016 Dec;1864(12):1667-1677. doi: 10.1016/j.bbapap.2016.08.019. Epub 2016 Sep 3.
- We report on the molecular interactions of the farnesoid X receptor (FXR) with prenylflavonoids, an emerging class of FXR modulators. FXR is an attractive therapeutic target for mitigating metabolic syndromes (MetS) because FXR activates the inhibitory nuclear receptor, small heterodimer partner (SH
- PMID 27596062
- Sirtuin 1 activation alleviates cholestatic liver injury in a cholic acid-fed mouse model of cholestasis.
- Kulkarni SR1, Soroka CJ1, Hagey LR2, Boyer JL1.
- Hepatology (Baltimore, Md.).Hepatology.2016 Dec;64(6):2151-2164. doi: 10.1002/hep.28826. Epub 2016 Oct 28.
- Sirtuin1 (Sirt1; mammalian homolog of Saccharomyces cerevisiae enzyme Sir2) is a transcriptional and transactivational regulator of murine farnesoid X receptor (Fxr), which is the primary bile acid (BA) sensor, and critical regulator of BA metabolism in physiological and pathophysiological condition
- PMID 27639250
Japanese Journal
- Cholestasis induces reversible accumulation of periplakin in mouse liver.
- Ito Shinji,Satoh Junko,Matsubara Tsutomu,Shah Yatrik M,Ahn Sung-Hoon,Anderson Cherie R,Shan Weiwei,Peters Jeffrey M,Gonzalez Frank J
- BMC gastroenterology 13, 2013-07
- … Because we observed a marked fluctuation of PPL expression in mouse liver in association with the bile acid receptor farnesoid X receptor (FXR) and cholestasis, we sought to characterize the role of PPL in the liver and determine its contributions to the etiology and pathogenesis of cholestasis. …
- NAID 120005307061
- Critical role of farnesoid X receptor for hepatocellular carcinoma cell proliferation
- Fujino Tomofumi,Takeuchi Airi,Maruko-Ohtake Akiko [他]
- The journal of biochemistry 152(6), 577-586, 2012-12
- NAID 40019523919
Related Links
- ... bile acids return to the liver to complete their enterohepatic circulation. The Farnesoid X receptor (FXR) is a member of the nuclear receptor superfamily and has emerged as a key player in the Key Words: bile acid FXR lipid ...
- hon p.5 [100%] 347 Table 2. Genes Regulated by FXR2,3) Gene Function Regulatory eŠect Reference SHP Nuclear receptor inhibitor Induced (18, 19) CYP7A1 Bile acid metabolism Bile acid synthesis Repressed (19) CYP8B1 Bile ...
★リンクテーブル★
[★]
- 英
- farnesoid X receptor、FXR
- 関
- ファルネソイドXレセプター
[★]
[★]
キサントシン, xanthosine